[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100444053":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":30,"centralContacts":35,"locations":44,"responsibleParty":60,"collaborators":10,"id":62,"slug":63,"hasResults":64,"nctId":65,"briefTitle":66,"officialTitle":67,"acronym":68,"eligibilityCriteria":69,"healthyVolunteers":64,"sex":70,"minAge":71,"maxAge":10,"enrollmentInfo":72,"targetDuration":10,"studyType":75,"phases":10,"briefSummary":76,"conditions":77,"keywords":10,"overallStatus":47,"whyStopped":10,"lastUpdateSubmitDate":79,"lastUpdatePostDateStruct":80,"startDateStruct":83,"completionDateStruct":85,"leadSponsor":87,"locationsCount":88},{"fullName":5,"class":6},"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","OTHER",[8,12,15,18,21,24,27],{"label":9,"type":10,"description":11,"interventionNames":10},"Cases 1",null,"Patients treated with JAK-type kinase inhibitors.",{"label":13,"type":10,"description":14,"interventionNames":10},"Cases 2","Patients treated with monoclonal antibodies against TNF.",{"label":16,"type":10,"description":17,"interventionNames":10},"Cases 3","Patients treated with soluble receptor against TNF.",{"label":19,"type":10,"description":20,"interventionNames":10},"Cases 4","Patients treated with FAME group biosimilars.",{"label":22,"type":10,"description":23,"interventionNames":10},"Cases 5","Patients treated with rituximab.",{"label":25,"type":10,"description":26,"interventionNames":10},"Cases 6","Patients treated with abatacept.",{"label":28,"type":10,"description":29,"interventionNames":10},"Cases 7","Patients treated with drugs that block the IL6.",[31],{"name":32,"affiliation":33,"role":34},"Blanca Estela Hernández Cruz","Hospital Universitario Virgen Macarena","PRINCIPAL_INVESTIGATOR",[36,40],{"name":32,"role":37,"phone":38,"phoneExt":10,"email":39},"CONTACT","955008000","blancahcruz@gmail.com",{"name":41,"role":37,"phone":42,"phoneExt":10,"email":43},"Carlos García Pérez","955 04 31 27","administracion.eecc.hvm.sspa@juntadeandalucia.es",[45],{"facility":46,"status":47,"city":48,"state":10,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Hospital Universitario Virgen macarena","RECRUITING","Seville","41009","Spain","ES",{"type":53,"coordinates":54},"Point",[55,56],-5.97317,37.38283,{"lat":56,"lon":55},[59],{"name":32,"role":37,"phone":38,"phoneExt":10,"email":39},{"type":61,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100444053","persistence-of-biological-treatment-and-inhibitors-of-jak-kinases-in-patients-with-rheumatoid-arthritis-100444053",false,"NCT05062421","Persistence of Biological Treatment and Inhibitors of Jak Kinases in Patients With Rheumatoid Arthritis.","Persistence of Biological Treatment and Inhibitors of Jak Kinases in Habitual Clinical Practice in Patients With Rheumatoid Arthritis. Influence of the Comorbidities.","Arthritis","Inclusion Criteria:\n\n* Patients aged ≥18 years.\n* With a diagnosis of Adult Rheumatoid Arthritis according to the 2010 ACR \u002F EULAR criteria.\n* Who have received at least one of the doses of the study drugs.\n* In follow-up in the consultations of the UGC of Rheumatology of the HUVM.\n* With at least two complete evaluations (baseline and final) of clinical variables.\n\nExclusion Criteria:\n\n* Patients where the medical records lack sufficient baseline and final variables to perform the analysis.\n* Patients in whom more than 50% of the variables to be collected are missing in the data collection.","ALL","18 Years",{"count":73,"type":74},540,"ESTIMATED","OBSERVATIONAL","One-center observational study aimed at determining the survival of patients with rheumatoid arthritis treated with targeted synthetic disease-modifying drugs (FAMEsd) and biologic disease-modifying drugs (FAMEb).\n\nThese patients will be administered a series of medications and a follow-up will be carried out to analyze their evolution.",[78],"Arthritis, Rheumatoid","2021-11-15",{"date":81,"type":82},"2021-11-17","ACTUAL",{"date":84,"type":82},"2021-04-01",{"date":86,"type":74},"2026-12-31",{"name":5,"class":6},1]